The aim of this prospective, randomised, open-label, multicentre clinical trial is to enhance
blood pressure control in primary care by introducing a standardised and simplified titration
regime with single pill combinations (SPC), comprising an angiotensin receptor blocker,
calcium channel blocker and hydrochlorothiazide.
Phase:
Phase 4
Details
Lead Sponsor:
Wilhelminenspital Vienna
Collaborators:
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology Ludwig Boltzmann Foundation for Cardiovascular Research